Adverse drug reactions (ADR) are common in the elderly and manifest themselves with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding. In the latest issue of the journal Pro Terza Età di ANASTE an article of mine has been published that illustrates how to manage this serious risk.
The topic was discussed at the DTx East conference in Boston where the risk assessment of digital therapies, how these risks differ from traditional drugs and how these differences could affect regulation were discussed. Continue reading →
Medication review, especially in patients who take a large number of drugs, can be very complex, like a Rubik’s cube with many elements. Medication Decision Support Systems can help clinicians solve the 3D puzzle of complex therapies.
Adverse drug reactions (ADRs) are a serious public health issue, being a major cause of morbidity and mortality. Clinical Decision Support Systems (CDSS) can reduce this phenomenon and the associated costs. Continue reading →